After a 20-year collaboration on the development and manufacture of Advil Liqui-Gels (ibuprofen), Catalent Pharma Solutions it has entered into an exclusive long-term supply agreement to produce the next generation of Pfizer’s leading over-the-counter (OTC) pain relief product with the launch of new Advil Liqui-Gels Minis, using Catalent’s softgel platform OptiGel Mini technology. The product delivers pain relief in a more concentrated fill resulting in a smaller, more convenient capsule. Sma...